[HTML][HTML] Preclinical evaluation of novel tyrosine-kinase inhibitors in medullary thyroid cancer

D Saronni, G Gaudenzi, A Dicitore, S Carra… - Cancers, 2022 - mdpi.com
Simple Summary Medullary thyroid carcinoma (MTC) is a neuroendocrine tumor arising from
parafollicular calcitonin-secreting C cells of the thyroid. Most of the patients affected by MTC …

Preclinical Evaluation of Novel Tyrosine-Kinase Inhibitors in Medullary Thyroid Cancer.

D Saronni, G Gaudenzi, A Dicitore, S Carra… - Cancers, 2022 - europepmc.org
Medullary thyroid carcinoma (MTC) is a neuroendocrine tumor arising from parafollicular C
cells of the thyroid gland. In this preclinical study, we tested three tyrosine-kinase inhibitors …

Preclinical Evaluation of Novel Tyrosine-Kinase Inhibitors in Medullary Thyroid Cancer

D Saronni, G Gaudenzi, A Dicitore, S Carra… - …, 2022 - pubmed.ncbi.nlm.nih.gov
Medullary thyroid carcinoma (MTC) is a neuroendocrine tumor arising from parafollicular C
cells of the thyroid gland. In this preclinical study, we tested three tyrosine-kinase inhibitors …

[PDF][PDF] Preclinical Evaluation of Novel Tyrosine-Kinase Inhibitors in Medullary Thyroid Cancer

D Saronni, G Gaudenzi, A Dicitore, S Carra… - Curr. Oncol, 2019 - pure.eur.nl
Medullary thyroid carcinoma (MTC) is a neuroendocrine tumor arising from parafollicular C
cells of the thyroid gland. In this preclinical study, we tested three tyrosine-kinase inhibitors …

Preclinical Evaluation of Novel Tyrosine-Kinase Inhibitors in Medullary Thyroid Cancer

D Saronni, G Gaudenzi, A Dicitore, S Carra… - CANCERS, 2022 - air.unimi.it
Abstract Simple Summary Medullary thyroid carcinoma (MTC) is a neuroendocrine tumor
arising from parafollicular calcitonin-secreting C cells of the thyroid. Most of the patients …

Preclinical Evaluation of Novel Tyrosine-Kinase Inhibitors in Medullary Thyroid Cancer.

D Saronni, G Gaudenzi, A Dicitore, S Carra… - Cancers, 2022 - go.gale.com
Medullary thyroid carcinoma (MTC) is a neuroendocrine tumor arising from parafollicular
calcitonin-secreting C cells of the thyroid. Most of the patients affected by MTC, especially …

[HTML][HTML] Preclinical Evaluation of Novel Tyrosine-Kinase Inhibitors in Medullary Thyroid Cancer

D Saronni, G Gaudenzi, A Dicitore, S Carra… - Cancers, 2022 - ncbi.nlm.nih.gov
Medullary thyroid carcinoma (MTC) is a neuroendocrine tumor arising from parafollicular C
cells of the thyroid gland. In this preclinical study, we tested three tyrosine-kinase inhibitors …

Preclinical Evaluation of Novel Tyrosine-Kinase Inhibitors in Medullary Thyroid Cancer

D Saronni, G Gaudenzi, A Dicitore, S Carra… - …, 2022 - search.proquest.com
Medullary thyroid carcinoma (MTC) is a neuroendocrine tumor arising from parafollicular C
cells of the thyroid gland. In this preclinical study, we tested three tyrosine-kinase inhibitors …

[PDF][PDF] Preclinical Evaluation of Novel Tyrosine-Kinase Inhibitors in Medullary Thyroid Cancer

D Saronni, G Gaudenzi, A Dicitore, S Carra… - Curr. Oncol, 2019 - air.unimi.it
Medullary thyroid carcinoma (MTC) is a neuroendocrine tumor arising from parafollicular C
cells of the thyroid gland. In this preclinical study, we tested three tyrosine-kinase inhibitors …

[PDF][PDF] Preclinical Evaluation of Novel Tyrosine-Kinase Inhibitors in Medullary Thyroid Cancer

D Saronni, G Gaudenzi, A Dicitore, S Carra… - Curr. Oncol, 2019 - pure.eur.nl
Medullary thyroid carcinoma (MTC) is a neuroendocrine tumor arising from parafollicular C
cells of the thyroid gland. In this preclinical study, we tested three tyrosine-kinase inhibitors …